AU8743001A - Moraxella polypeptides and corresponding dna fragments and uses thereof - Google Patents

Moraxella polypeptides and corresponding dna fragments and uses thereof

Info

Publication number
AU8743001A
AU8743001A AU8743001A AU8743001A AU8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A
Authority
AU
Australia
Prior art keywords
uses
dna fragments
corresponding dna
moraxella polypeptides
moraxella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8743001A
Inventor
Loosmore Sheena
Wang Joe
Bradley Bill
Ochs Martina
Yang Yan-Ping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22829600P priority Critical
Priority to US22829400P priority
Priority to US22829500P priority
Priority to US22844100P priority
Priority to US22844000P priority
Priority to US22843900P priority
Priority to US22851100P priority
Priority to US22844200P priority
Priority to US22851200P priority
Priority to US22874200P priority
Priority to US22844300P priority
Priority to US22877300P priority
Priority to US22843800P priority
Priority to US22947500P priority
Priority to US22946500P priority
Priority to US22947400P priority
Priority to US22947800P priority
Priority to US22980600P priority
Priority to US22980900P priority
Priority to US22974000P priority
Priority to US22980300P priority
Priority to US22981100P priority
Priority to US22980400P priority
Priority to US22980500P priority
Priority to US23025000P priority
Priority to US23021400P priority
Priority to US23025200P priority
Application filed by Aventis Pasteur Ltd filed Critical Aventis Pasteur Ltd
Priority to PCT/CA2001/001221 priority patent/WO2002018595A2/en
Publication of AU8743001A publication Critical patent/AU8743001A/en
Application status is Pending legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
AU8743001A 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof Pending AU8743001A (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
US22829400P true 2000-08-28 2000-08-28
US22829500P true 2000-08-28 2000-08-28
US22829600P true 2000-08-28 2000-08-28
US22844000P true 2000-08-29 2000-08-29
US22843900P true 2000-08-29 2000-08-29
US22851100P true 2000-08-29 2000-08-29
US22844200P true 2000-08-29 2000-08-29
US22851200P true 2000-08-29 2000-08-29
US22874200P true 2000-08-29 2000-08-29
US22844300P true 2000-08-29 2000-08-29
US22877300P true 2000-08-29 2000-08-29
US22843800P true 2000-08-29 2000-08-29
US22844100P true 2000-08-29 2000-08-29
US22946500P true 2000-09-01 2000-09-01
US22947400P true 2000-09-01 2000-09-01
US22947800P true 2000-09-01 2000-09-01
US22947500P true 2000-09-01 2000-09-01
US22980900P true 2000-09-05 2000-09-05
US22974000P true 2000-09-05 2000-09-05
US22980300P true 2000-09-05 2000-09-05
US22981100P true 2000-09-05 2000-09-05
US22980400P true 2000-09-05 2000-09-05
US22980500P true 2000-09-05 2000-09-05
US22980600P true 2000-09-05 2000-09-05
US23021400P true 2000-09-06 2000-09-06
US23025200P true 2000-09-06 2000-09-06
US23025000P true 2000-09-06 2000-09-06
PCT/CA2001/001221 WO2002018595A2 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU8743001A true AU8743001A (en) 2002-03-13

Family

ID=27586817

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8743001A Pending AU8743001A (en) 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (2) AU8743001A (en)
WO (1) WO2002018595A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092625A2 (en) * 2001-05-15 2002-11-21 Shire Biochem Inc. Moraxella(branhamella) catarrhalis antigens
WO2003043986A1 (en) 2001-11-16 2003-05-30 Shire Biochem Inc Polypeptides of moraxella (branhamella) catarrhalis
EP1765313A2 (en) 2004-06-24 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP1945247A1 (en) 2005-10-18 2008-07-23 Novartis Vaccines and Diagnostics, Inc. Mucosal and systemic immunizations with alphavirus replicon particles
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
EP2010537B1 (en) 2006-03-23 2011-12-28 Novartis AG Imidazoquinoxaline compounds as immunomodulators
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
AU2008339551B2 (en) 2007-12-21 2013-10-24 Glaxosmithkline Biologicals S.A. Mutant forms of streptolysin O
EA018068B1 (en) 2008-03-03 2013-05-30 Айрм Ллк Compounds and compositions as tlr activity modulators
CN102481349B (en) 2009-01-12 2014-10-15 诺华股份有限公司 Cna_b domain antigens in vaccines against gram positive bacteria
JP5867952B2 (en) 2009-06-10 2016-02-24 ノバルティス アーゲー Benzonaphthyridine-containing vaccine
ES2596653T3 (en) 2009-06-16 2017-01-11 Glaxosmithkline Biologicals Sa Opsonization bactericidal and antibody-dependent assays mediated by high-performance complement
TWI445708B (en) 2009-09-02 2014-07-21 Irm Llc Compounds and compositions as tlr activity modulators
MX2012002723A (en) 2009-09-02 2012-04-11 Novartis Ag Immunogenic compositions including tlr activity modulators.
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
BR112012014624A8 (en) 2009-12-15 2017-12-26 Novartis Ag homogeneous suspension of immunopotentiation compounds and uses of these
EA031379B1 (en) 2010-03-23 2018-12-28 Новартис Аг Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
EP2575988A1 (en) 2010-05-28 2013-04-10 Tetris Online, Inc. Interactive hybrid asynchronous computer game infrastructure
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
GB201102091D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
GB201102090D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
US9827190B2 (en) 2013-02-01 2017-11-28 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6541616B1 (en) * 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
GB9921691D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Also Published As

Publication number Publication date
WO2002018595A9 (en) 2007-08-23
WO2002018595A2 (en) 2002-03-07
WO2002018595A3 (en) 2002-10-03
AU2001287430A8 (en) 2002-03-13
AU2001287430A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
DK1842918T3 (en) Receptor nucleic acids and receptor polypeptides
DE60036698D1 (en) Chlamydia antigenes and corresponding dna fragments and its uses
AU2002246534A1 (en) Resistive heaters and uses thereof
AU2017702A (en) Selectable multi-purpose card
IL138608D0 (en) Antibody variants and fragments thereof
GB0103424D0 (en) Gonococcus proteins
AU1453102A (en) Novel proteins and nucleic acids encoding same
AU7171401A (en) B7-like polynucleotides, polypeptides, and antibodies
IL161769D0 (en) Anbtimicrobial polypeptides from pseudoplectania nigrella
AU2002313749A1 (en) Biochemistry-related polynucleotides and polypeptides in plants
EP1490386A4 (en) Novel polypeptides and nucleic acids encoding the same
AU3651002A (en) Seed-preferred regulatory elements and uses thereof
AU7528501A (en) B7-related nucleic acids and polypeptides useful for immunomodulation
AU2002326877A1 (en) Novel nucleic acids and polypeptides
ZA200309523B (en) ß-Amyloid peptide-binding proteins and polynucleotides encoding the same
HRP20000714A2 (en) NOVEL CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
AU2002341541A1 (en) Abiotic stress responsive polynucleotides and polypeptides
EP1572881A4 (en) Tacis and br3 polypeptides and uses thereof
DK1265914T3 (en) WNT-1-related polypeptides and nucleic acids encoding the same
DE60037900D1 (en) Chlamydia antigens and corresponding dna fragments and its uses
AU2001288858A1 (en) Receptor nucleic acids and polypeptides
EP1519942A4 (en) B7-related nucleic acids and polypeptides useful for immunomodulation
AT463575T (en) Chlamydia antigene, corresponding dna fragments and its uses
AU6519801A (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
DE60125350D1 (en) Chlamydia antigene, corresponding dna fragments and its uses